Sage Therapeutics SG&A Expense (TTM) Trends

Sage Therapeutics Inc (SAGE)

7.29 +0.12 (+1.67%) USD | NASDAQ | Sep 27, 16:00

7.275 -0.02 (-0.21%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
June 30, 2024	241.81M
March 31, 2024	261.39M
December 31, 2023	274.52M
September 30, 2023	286.74M
June 30, 2023	270.08M
March 31, 2023	250.06M
December 31, 2022	230.83M
September 30, 2022	215.10M
June 30, 2022	202.33M
March 31, 2022	190.13M
December 31, 2021	183.50M
September 30, 2021	185.40M
June 30, 2021	171.79M
March 31, 2021	166.67M
December 31, 2020	196.95M
September 30, 2020	228.58M
June 30, 2020	281.98M
March 31, 2020	331.99M
December 31, 2019	345.78M
September 30, 2019	336.34M
June 30, 2019	301.53M

Date	Value
March 31, 2019	256.47M
December 31, 2018	201.40M
September 30, 2018	145.27M
June 30, 2018	107.66M
March 31, 2018	79.45M
December 31, 2017	62.88M
September 30, 2017	57.70M
June 30, 2017	50.60M
March 31, 2017	44.55M
December 31, 2016	39.41M
September 30, 2016	33.27M
June 30, 2016	30.88M
March 31, 2016	28.43M
December 31, 2015	25.29M
September 30, 2015	20.47M
June 30, 2015	16.74M
March 31, 2015	12.09M
December 31, 2014	9.709M
September 30, 2014	7.496M
June 30, 2014	5.738M
March 31, 2014	4.732M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

166.67M

Minimum

Mar 2021

345.78M

Maximum

Dec 2019

242.60M

Average

236.32M

Median

SG&A Expense (TTM) Benchmarks